Frédéric Thuaud

Molecular Pathways: The eIF4F Translation Initiation Complex—New Opportunities for Cancer Treatment

Cancer nanomedicine: progress, challenges and opportunities

An ionizable lipid toolbox for RNA delivery

Simple indole alkaloids and those with a nonrearranged monoterpenoid unit

Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain

Widespread Translational Remodeling during Human Neuronal Differentiation

Targeting the translation machinery in cancer

AKT/PKB Signaling: Navigating the Network

The PI3K Pathway in Human Disease

The Golden Age of Transfer Hydrogenation

Bioactive Benzofuran derivatives: A review

Progress towards the Total Synthesis of the Bioactive Calothrixins A and B

Occurrence, Biogenesis, and Synthesis of Biologically Active Carbazole Alkaloids

Nanotechnology for Multimodal Synergistic Cancer Therapy

Multifunctional Envelope-Type siRNA Delivery Nanoparticle Platform for Prostate Cancer Therapy

Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box

Current Applications of Suzuki–Miyaura Coupling Reaction in The Total Synthesis of Natural Products: An update

Biomimetic Kinetic Resolution: Highly Enantio- and Diastereoselective Transfer Hydrogenation of Aglain Ketones To Access Flavagline Natural Products

Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment

Signalling to eIF4E in cancer

Prescribed drugs containing nitrogen heterocycles: an overview

Benzofuran derivatives as a novel class of inhibitors of mTOR signaling

Flavaglines Alleviate Doxorubicin Cardiotoxicity: Implication of Hsp27

Benzofuran derivatives as anticancer inhibitors of mTOR signaling

Selective anticancer effects of a synthetic flavagline on human Oct4-expressing cancer stem-like cells via a p38 MAPK-dependent caspase-3-dependent pathway

Prohibitin Ligands in Cell Death and Survival: Mode of Action and Therapeutic Potential

eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies

The Natural Anticancer Compounds Rocaglamides Inhibit the Raf-MEK-ERK Pathway by Targeting Prohibitin 1 and 2

Synthesis of a Calothrixin B Isomer with a Novel 7H-Indolo[2,3-j]phenanthridine-7,13(8H)-dione Structure

Flavaglines: Potent Anticancer Drugs that Target Prohibitins and the Helicase eIF4A

Novel Flavaglines Displaying Improved Cytotoxicity